Abstract
Intensive research investigating the relation between the management of glycemia and outcome in patients receiving neurocritical care has underlined the possible benefits and adverse events related to glucose control. Here, we review experimental and clinical studies investigating the effects of hypoglycemia and hyperglycemia on the brain that advance current knowledge on managing glycemia in patients receiving neurocritical care.
MeSH terms
-
Animals
-
Blood Glucose / metabolism*
-
Critical Care*
-
Humans
-
Hyperglycemia / complications
-
Hyperglycemia / therapy*
-
Hypoglycemia / complications
-
Hypoglycemia / therapy*
-
Nervous System Diseases / blood*
-
Nervous System Diseases / pathology
-
Nervous System Diseases / therapy*
-
Neurons / pathology
-
Stress, Physiological / drug effects
-
Stress, Physiological / physiology
-
Trauma, Nervous System / blood*
-
Trauma, Nervous System / pathology
-
Trauma, Nervous System / therapy*
-
Treatment Outcome